In furtherance to its earlier intimation dated 23rd January, 2026 with regard to conference call to discuss the Q3FY26 and 9MFY26 financial results to held on Friday, February 13, 2026 at 4:00 pm. With reference to relevant provisions of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Alkem Laboratories has informed that a conference call to discuss the Q3FY26 and 9MFY26 financial results will now be held on Friday, February 13, 2026 at 5.00 pm. The company has enclosed the updated conference call details.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: